Refining basal insulin therapy: what have we learned in the age of analogues?
Author:
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference58 articles.
1. Insulin Analogues
2. Lower Within-Subject Variability of Insulin Detemir in Comparison to NPH Insulin and Insulin Glargine in People With Type 1 Diabetes
3. Hypoglycemia as a barrier to glycemic control
4. Negotiating the Barrier of Hypoglycemia in Diabetes
5. New insulins in the treatment of diabetes mellitus
Cited by 85 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once‐weekly dosing for the treatment of patients with diabetes;Diabetes, Obesity and Metabolism;2023-01-09
2. Factors Affecting Performance of Insulin Pen Injector Technology: A Narrative Review;Journal of Diabetes Science and Technology;2022-12-20
3. A glorious past, dynamic present and a promising future: Insulin at 100;Journal of the Royal College of Physicians of Edinburgh;2022-03
4. Comparison of efficacy of detemir and degludec insulin in the management of children and adolescents with type 1 diabetes;Journal of Diabetology;2022
5. Management of hyperglycemia in critical care;Journal of Diabetology;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3